Cibus Inc./$CBUS
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Cibus Inc.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
Ticker
$CBUS
Sector
Primary listing
Industry
Biotechnology
Headquarters
Employees
158
ISIN
US17166A1016
Website
Cibus Inc. Metrics
BasicAdvanced
$75M
-
-$10.27
1.71
-
Price and volume
Market cap
$75M
Beta
1.71
52-week high
$3.40
52-week low
$1.40
Average daily volume
587K
Financial strength
Current ratio
1.232
Quick ratio
1.168
Long term debt to equity
322.597
Total debt to equity
329.197
Interest coverage (TTM)
-2.31%
Profitability
EBITDA (TTM)
-72.433
Gross margin (TTM)
100.00%
Net profit margin (TTM)
-5,784.87%
Operating margin (TTM)
-1,665.59%
Effective tax rate (TTM)
-0.01%
Revenue per employee (TTM)
$30,000
Management effectiveness
Return on assets (TTM)
-11.39%
Return on equity (TTM)
-154.97%
Valuation
Price to revenue (TTM)
8.677
Price to book
0.72
Price to tangible book (TTM)
-0.26
Price to free cash flow (TTM)
-0.72
Free cash flow yield (TTM)
-138.90%
Free cash flow per share (TTM)
-213.90%
Growth
Revenue change (TTM)
104.78%
Earnings per share change (TTM)
-45.07%
3-year revenue growth (CAGR)
-39.65%
3-year earnings per share growth (CAGR)
-31.57%
Cibus Inc. News
AllArticlesVideos
The U.S. Food and Drug Administration Completes Review of Cibus' Altered Lignin Alfalfa Developed in Partnership with S&W Seed Company for use in Livestock Feed
GlobeNewsWire·4 days ago
Cibus and John Innes Centre Announce Ongoing Collaboration with Potential to Revolutionize Fertilizer Use in Farming
GlobeNewsWire·2 weeks ago
Cibus, Inc. Announces Closing of $27.5 Million Public Offering
GlobeNewsWire·3 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Cibus Inc. stock?
Cibus Inc. (CBUS) has a market cap of $75M as of June 28, 2025.
What is the P/E ratio for Cibus Inc. stock?
The price to earnings (P/E) ratio for Cibus Inc. (CBUS) stock is 0 as of June 28, 2025.
Does Cibus Inc. stock pay dividends?
No, Cibus Inc. (CBUS) stock does not pay dividends to its shareholders as of June 28, 2025.
When is the next Cibus Inc. dividend payment date?
Cibus Inc. (CBUS) stock does not pay dividends to its shareholders.
What is the beta indicator for Cibus Inc.?
Cibus Inc. (CBUS) has a beta rating of 1.71. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.